NOVAVAX Reports Progress Under Joint Venture in India With Cadila Pharmaceuticals
Published: Tuesday, January 03, 2012 Last Updated: Tuesday, January 03, 2012
The company announced that CPL Biologics (CPLB), its joint venture in India with Cadila Pharmaceuticals Ltd., has made significant progress with its vaccine-development programs in 2011 and is preparing to initiate clinical studies of vaccine candidates to prevent influenza and rabies in 2012 and 2013, respectively.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.